test

Harold Schaaff

@Soleus Capital Management, L.p.

Latest period2024 - Q3ReportedManaged Assets$1.291BTotal holdings87
Assets growth rate13.9%Assets growth rate (2-Q avg)-0.97%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Soleus Capital Management, L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 87 positions.

Assets under management

The assets under management (AUM) of Soleus Capital Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.291B in assets, with a quarterly growth rate of 13.9% and a 2-quarter average growth rate of -0.97%. The portfolio is managed by Harold Schaaff, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
VSTMVerastem Inc
Recent Activity
Increased 70.23%
0.66%
$8.456M
2.828M shares@ $2.99 avg price
ENTAEnanta Pharmaceuticals Inc
Recent Activity
Decreased -1.75%
0.64%
$8.138M
785,546 shares@ $10.37 avg price
KIDSOrthopediatrics Corp
Recent Activity
Decreased -6.64%
0.61%
$7.833M
288,945 shares@ $27.12 avg price
ACLXArcellx Inc
Recent Activity
Decreased -45.51%
0.61%
$7.769M
93,031 shares@ $83.52 avg price
NUVLNuvalent Inc
Recent Activity
Decreased -56.71%
0.59%
$7.607M
74,357 shares@ $102.3 avg price
KNSAKiniksa Pharmaceuticals Intl
Recent Activity
Increased 51.25%
0.59%
$7.559M
302,500 shares@ $24.99 avg price
BDSXBiodesix Inc
Recent Activity
Decreased -33.93%
0.56%
$7.188M
4.038M shares@ $1.79 avg price
TAKTakeda Pharmaceutical Co Ltd
Recent Activity
New Position
0.56%
$7.11M
500,000 shares@ $14.22 avg price
RLAYRelay Therapeutics Inc
Recent Activity
New Position
0.5%
$6.443M
910,000 shares@ $7.08 avg price
SMMTSummit Therapeutics Inc
Recent Activity
New Position
0.49%
$6.242M
285,000 shares@ $21.9 avg price